Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

  1. Perez, M.
  2. Lucena-Cacace, A.
  3. Marín-Gómez, L.M.
  4. Padillo-Ruiz, J.
  5. Robles-Frias, M.J.
  6. Saez, C.
  7. Garcia-Carbonero, R.
  8. Carnero, A.
Journal:
Oncotarget

ISSN: 1949-2553

Year of publication: 2016

Volume: 7

Issue: 22

Pages: 33111-33124

Type: Article

DOI: 10.18632/ONCOTARGET.8880 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus